Methylphenidate Hydrochloride Capsule, Extended Release
Product Images NDC 0591-3873

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Methylphenidate Hydrochloride (NDC 0591-3873). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 1)

1 (Image 1)
Chemical structure diagram of methylphenidate hydrochloride showing molecular bonds, functional groups, and hydrochloride (HCl) component.*
FDA Label Image

Container Label (Image 10)

Container Label (Image 10)
Label for methylphenidate hydrochloride extended-release capsules, 60 mg strength, by Actavis Pharma, Inc. The label indicates the product is for once daily oral use, prescription only, and contains 90 capsules. It includes instructions for pharmacists to dispense the Medication Guide and storage details, along with manufacturer information for Teva Pharmaceuticals.*
FDA Label Image

1 (Image 2)

1 (Image 2)
A pharmacokinetic graph showing plasma concentration (ng/mL) over time (hours) for methylphenidate hydrochloride 80 mg in two formulations: capsule and sprinkle. The graph depicts concentration changes from 0 to 24 hours post-dose, comparing the two delivery methods.*
FDA Label Image

2 (Image 3)

2 (Image 3)
A line graph comparing SKAMP total scores over 14 hours between placebo and methylphenidate hydrochloride extended-release. The x-axis represents time in hours from 0 to 14, and the y-axis shows SKAMP total scores. Two data series are shown: placebo with a square marker increasing over time, and methylphenidate hydrochloride extended-release with a triangle marker remaining lower throughout the period.*
FDA Label Image

Container Label (Image 4)

Container Label (Image 4)
Label for methylphenidate hydrochloride extended-release capsules, 10 mg strength, by Actavis Pharma, Inc. It indicates a once daily oral dosage form with 90 capsules per bottle. The label includes instructions for pharmacists to dispense the accompanying medication guide, storage conditions, and child-resistant packaging information. The label also features a barcode and serialization coding area.*
FDA Label Image

Container Label (Image 5)

Container Label (Image 5)
Label for methylphenidate hydrochloride extended-release capsules, 15 mg strength. The label states once daily dosage, contains 90 capsules, and is for prescription use only. Labeler is Actavis Pharma, Inc. (Teva Pharmaceuticals). Includes storage instructions, capsule identification details, and a barcode with lot and expiration information.*
FDA Label Image

Container Label (Image 6)

Container Label (Image 6)
Label for methylphenidate hydrochloride extended-release capsules 20 mg by Actavis Pharma, Inc. The label indicates once daily oral dosing, contains 90 capsules, and includes storage instructions and cautions. It also mentions the capsule identification with 'A869' on the cap and '20 mg' on the body, and directs to dispense the medication guide with each prescription.*
FDA Label Image

Container Label (Image 7)

Container Label (Image 7)
Label for methylphenidate hydrochloride extended-release capsules 30 mg by Actavis Pharma, Inc. The label states 'Once Daily' and contains 90 capsules. It includes directions for pharmacists to dispense the medication guide, storage instructions, dosage note, and a barcode. The label features the Teva logo and a serialization coding area on the right.*
FDA Label Image

Container Label (Image 8)

Container Label (Image 8)
Label for methylphenidate hydrochloride extended-release capsules, 40 mg strength, in a 90-capsule bottle. The label includes dosing instructions, packaging warnings, and dispensing information by Actavis Pharma, Inc. The label also displays the NDC number 0591-3891-19, barcode, and Teva branding.*
FDA Label Image

Container Label (Image 9)

Container Label (Image 9)
Label for methylphenidate hydrochloride extended-release capsules, 50 mg strength, in a 90-capsule bottle. The label includes directions to dispense the Medication Guide and notes it is for Rx only. Manufactured by Teva Pharmaceuticals, it features dosing and storage information as well as a barcode and serialization coding area.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.